REFERENCES
1. Cunningham C, O' Sullivan R, Caserotti P, Tully MA. Consequences of physical inactivity in older adults: a systematic review of reviews and meta-analyses. Scand J Med Sci Sports 2020;30:816-27.
2. Patterson SL, Trupin L, Yazdany J, et al. Physical inactivity and incident depression in a multiracial, multiethnic systemic lupus erythematosus cohort. Arthritis Care Res 2022;74:1098-104.
3. Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 2009;39:3-11.
4. Santiago JA, Quinn JP, Potashkin JA. Physical activity rewires the human brain against neurodegeneration. Int J Mol Sci 2022;23:6223.
5. Sujkowski A, Hong L, Wessells RJ, Todi SV. The protective role of exercise against age-related neurodegeneration. Ageing Res Rev 2022;74:101543.
6. López-Ortiz S, Lista S, Valenzuela PL, et al. Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses. J Neurol 2023;270:711-25.
7. Gubert C, Hannan AJ. Exercise mimetics: harnessing the therapeutic effects of physical activity. Nat Rev Drug Discov 2021;20:862-79.
8. Freitas GB, Lourenco MV, De Felice FG. Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease. J Neurochem 2020;155:602-11.
9. Gholamnezhad Z, Boskabady MH, Jahangiri Z. Exercise and Dementia. In: Xiao J, editor. Physical exercise for human health. Singapore: Springer; 2020. pp. 303-15.
10. da Costa Daniele TM, de Bruin PFC, de Matos RS, et al. Exercise effects on brain and behavior in healthy mice, Alzheimer's disease and Parkinson's disease model-A systematic review and meta-analysis. Behav Brain Res 2020;383:112488.
11. Sawan C, Vaissière T, Murr R, Herceg Z. Epigenetic drivers and genetic passengers on the road to cancer. Mutat Res 2008;642:1-13.
12. Turek-Plewa J, Jagodziński PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett; 2005.10.631-47.
13. Lyko F. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation. Nat Rev Genet 2018;19:81-92.
14. Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet 2017;18:517-34.
15. Loenarz C, Schofield CJ. Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem Biol 2009;16:580-3.
16. Inoue A, Zhang Y. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 2011;334:194.
17. Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011;333:1300-3.
18. Rea S, Eisenhaber F, O'Carroll D, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000;406:593-9.
20. Earls LR, Westmoreland JJ, Zakharenko SS. Non-coding RNA regulation of synaptic plasticity and memory: implications for aging. Ageing Res Rev 2014;17:34-42.
21. Feng J, Zhou Y, Campbell SL, et al. Dnmt1 and dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010;13:423-30.
22. Maddox SA, Watts CS, Schafe GE. DNA methyltransferase activity is required for memory-related neural plasticity in the lateral amygdala. Neurobiol Learn Mem 2014;107:93-100.
23. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007;53:857-69.
24. Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 2008;28:10576-86.
25. Levenson JM, Roth TL, Lubin FD, et al. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 2006;281:15763-73.
26. Argyrousi EK, de Nijs L, Lagatta DC, et al. Effects of DNA methyltransferase inhibition on pattern separation performance in mice. Neurobiol Learn Mem 2019;159:6-15.
27. Miller CA, Gavin CF, White JA, et al. Cortical DNA methylation maintains remote memory. Nat Neurosci 2010;13:664-6.
28. Taylor RM, Smith R, Collins CE, et al. Global DNA methylation and cognitive and behavioral outcomes at 4 years of age: A cross-sectional study. Brain Behav 2020;10:e01579.
29. Schiepers OJ, van Boxtel MP, de Groot RH, et al. DNA methylation and cognitive functioning in healthy older adults. Br J Nutr 2012;107:744-8.
30. Collins BE, Greer CB, Coleman BC, Sweatt JD. Histone H3 lysine K4 methylation and its role in learning and memory. Epigenetics Chromatin 2019;12:7.
31. Keiser AA, Wood MA. Examining the contribution of histone modification to sex differences in learning and memory. Learn Mem 2019;26:318-31.
32. Geng H, Chen H, Wang H, Wang L. The histone modifications of neuronal plasticity. Neural Plast 2021;2021:6690523.
33. Maity S, Farrell K, Navabpour S, Narayanan SN, Jarome TJ. Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer’s disease. Int J Mol Sci 2021;22:12280.
34. Gupta S, Kim SY, Artis S, et al. Histone methylation regulates memory formation. J Neurosci 2010;30:3589-99.
35. Jakovcevski M, Ruan H, Shen EY, et al. Neuronal kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory. J Neurosci 2015;35:5097-108.
36. Webb WM, Sanchez RG, Perez G, et al. Dynamic association of epigenetic H3K4me3 and DNA 5hmC marks in the dorsal hippocampus and anterior cingulate cortex following reactivation of a fear memory. Neurobiol Learn Mem 2017;142:66-78.
37. Jarome TJ, Perez GA, Hauser RM, Hatch KM, Lubin FD. EZH2 Methyltransferase activity controls pten expression and mtor signaling during fear memory reconsolidation. J Neurosci 2018;38:7635-48.
38. Gupta-Agarwal S, Franklin AV, Deramus T, et al. G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J Neurosci 2012;32:5440-53.
39. Gupta-Agarwal S, Jarome TJ, Fernandez J, Lubin FD. NMDA receptor- and ERK-dependent histone methylation changes in the lateral amygdala bidirectionally regulate fear memory formation. Learn Mem 2014;21:351-62.
40. Peixoto L, Abel T. The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 2013;38:62-76.
42. Alarcón JM, Malleret G, Touzani K, et al. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004;42:947-59.
43. Maurice T, Duclot F, Meunier J, et al. Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice. Neuropsychopharmacology 2008;33:1584-602.
44. Guan JS, Haggarty SJ, Giacometti E, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009;459:55-60.
45. Wang WH, Cheng LC, Pan FY, et al. Intracellular trafficking of histone deacetylase 4 regulates long-term memory formation. Anat Reck 2011;294:1025-34.
46. Sando R 3rd, Gounko N, Pieraut S, Liao L, Yates J 3rd, Maximov A. HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 2012;151:821-34.
47. Kim MS, Akhtar MW, Adachi M, et al. An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci 2012;32:10879-86.
48. Agis-Balboa RC, Pavelka Z, Kerimoglu C, Fischer A. Loss of HDAC5 impairs memory function: implications for Alzheimer’s disease. J Alzheimers Dis 2013;33:35-44.
49. Gräff J, Woldemichael BT, Berchtold D, Dewarrat G, Mansuy IM. Dynamic histone marks in the hippocampus and cortex facilitate memory consolidation. Nat Commun 2012;3:991.
50. Chwang WB, O'Riordan KJ, Levenson JM, Sweatt JD. ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem 2006;13:322-8.
51. Chwang WB, Arthur JS, Schumacher A, Sweatt JD. The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J Neurosci 2007;27:12732-42.
52. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 2003;423:655-9.
53. Lubin FD, Sweatt JD. The IkappaB kinase regulates chromatin structure during reconsolidation of conditioned fear memories. Neuron 2007;55:942-57.
54. Jarome TJ, Perez GA, Webb WM, et al. Ubiquitination of histone H2B by proteasome subunit rpt6 controls histone methylation chromatin dynamics during memory formation. Biol Psychiatry 2021;89:1176-87.
55. Miller CA, Campbell SL, Sweatt JD. DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol Learn Mem 2008;89:599-603.
56. Koshibu K, Gräff J, Beullens M, et al. Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci 2009;29:13079-89.
57. Koshibu K, Gräff J, Mansuy IM. Nuclear protein phosphatase-1: an epigenetic regulator of fear memory and amygdala long-term potentiation. Neuroscience 2011;173:30-6.
58. Gräff J, Tsai LH. Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 2013;14:97-111.
59. Grinman E, Espadas I, Puthanveettil SV. Emerging roles for long noncoding RNAs in learning, memory and associated disorders. Neurobiol Learn Mem 2019;163:107034.
60. Woldemichael BT, Mansuy IM. Micro-RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics. Biochem Pharmacol 2016;104:1-7.
61. Barry G. Integrating the roles of long and small non-coding RNA in brain function and disease. Mol Psychiatry 2014;19:410-6.
62. Im HI, Kenny PJ. MicroRNAs in neuronal function and dysfunction. Trends Neurosci 2012; 35:325-334.
63. Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010;466:1105-9.
64. Daswani R, Gilardi C, Soutschek M, et al. MicroRNA-138 controls hippocampal interneuron function and short-term memory in mice. Elife 2022;11:e74056.
65. Landry CD, Kandel ER, Rajasethupathy P. New mechanisms in memory storage: piRNAs and epigenetics. Trends Neurosci 2013; 36:535-542.
66. Rajasethupathy P, Antonov I, Sheridan R, et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 2012;149:693-707.
67. Leighton LJ, Wei W, Marshall PR, et al. Disrupting the hippocampal Piwi pathway enhances contextual fear memory in mice. Neurobiol Learn Mem 2019;161:202-9.
68. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775-89.
69. Spadaro PA, Flavell CR, Widagdo J, et al. Long noncoding RNA-directed epigenetic regulation of gene expression is associated with anxiety-like behavior in mice. Biol Psychiatry 2015;78:848-59.
70. Wen X, Han XR, Wang YJ, et al. Down-regulated long non-coding RNA ANRIL restores the learning and memory abilities and rescues hippocampal pyramidal neurons from apoptosis in streptozotocin-induced diabetic rats via the NF-κB signaling pathway. J Cell Biochem 2018;119:5821-5833.
71. Butler AA, Johnston DR, Kaur S, Lubin FD. Long noncoding RNA NEAT1 mediates neuronal histone methylation and age-related memory impairment. Sci Signal 2019:12.
72. Sarangdhar MA, Chaubey D, Bhatt A, et al. A novel long non-coding RNA, durga modulates dendrite density and expression of kalirin in zebrafish. Front Mol Neurosci 2017;10:95.
74. Nikolac Perkovic M, Videtic Paska A, Konjevod M, et al. Epigenetics of Alzheimer's disease. Biomolecules 2021;11:195.
75. Qazi TJ, Quan Z, Mir A, Qing H. Epigenetics in Alzheimer's disease: perspective of dna methylation. Mol Neurobiol 2018;55:1026-1044.
76. Lord J, Cruchaga C. The epigenetic landscape of Alzheimer's disease. Nat Neurosci 2014;17:1138-40.
77. Migliore L, Coppedè F. Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 2022;18:643-60.
78. Gasparoni G, Bultmann S, Lutsik P, et al. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex. Epigenetics Chromatin 2018;11:41.
79. Lardenoije R, Roubroeks JAY, Pishva E, et al. Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood. Clin Epigenetics 2019;11:164.
80. Haertle L, Müller T, Lardenoije R, et al. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation. Clin Epigenetics 2019;11:195.
81. Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Genda Y, Ukitsu M. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res Mol Brain Res 1999;70:288-92.
82. West RL, Lee JM, Maroun LE. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci 1995;6:141-6.
83. Li P, Marshall L, Oh G, et al. Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer's disease pathology and cognitive symptoms. Nat Commun 2019;10:2246.
84. Foraker J, Millard SP, Leong L, et al. The APOE gene is differentially methylated in Alzheimer's disease. J Alzheimers Dis 2015;48:745-55.
85. Ferri E, Arosio B, D'Addario C, et al. Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease. J Neurol Sci 2016;362:283-6.
86. Nicolia V, Fuso A, Cavallaro RA, Di Luzio A, Scarpa S. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. J Alzheimers Dis 2010;19:895-907.
87. Smith AR, Smith RG, Burrage J, et al. A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases. Neurobiol Aging 2019;74:70-6.
88. Pathak GA, Silzer TK, Sun J, et al. Genome-wide methylation of mild cognitive impairment in mexican americans highlights genes involved in synaptic transport, Alzheimer’s disease-precursor phenotypes, and metabolic morbidities. J Alzheimers Dis 2019;72:733-49.
89. Mano T, Nagata K, Nonaka T, et al. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer’s disease. Proc Natl Acad Sci USA 2017;114:E9645-54.
90. Semick SA, Bharadwaj RA, Collado-Torres L, et al. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease. Acta Neuropathol 2019;137:557-69.
91. Smith AR, Smith RG, Pishva E, et al. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease. Clin Epigenetics 2019;11:52.
92. Hernández HG, Sandoval-Hernández AG, Garrido-Gil P, et al. Alzheimer’s disease DNA methylome of pyramidal layers in frontal cortex: laser-assisted microdissection study. Epigenomics 2018;10:1365-82.
93. Kaut O, Ramirez A, Pieper H, Schmitt I, Jessen F, Wüllner U. DNA methylation of the TNF-α promoter region in peripheral blood monocytes and the cortex of human Alzheimer's disease patients. Dement Geriatr Cogn Disord 2014;38:10-5.
94. Smith RG, Hannon E, De Jager PL, et al. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology. Alzheimers Dement 2018;14:1580-8.
95. Bustos FJ, Ampuero E, Jury N, et al. Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer’s disease mice. Brain 2017;140:3252-68.
96. Sanchez-Mut JV, Heyn H, Silva BA, et al. PM20D1 is a quantitative trait locus associated with Alzheimer’s disease. Nat Med 2018;24:598-603.
97. Marques SC, Lemos R, Ferreiro E, et al. Epigenetic regulation of BACE1 in Alzheimer’s disease patients and in transgenic mice. Neuroscience 2012;220:256-66.
98. Lu X, Deng Y, Yu D, et al. Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer’s disease. PLoS One 2014;9:e103067.
99. Kumar A, Thakur MK. Epigenetic regulation of presenilin 1 and 2 in the cerebral cortex of mice during development. Dev Neurobiol 2015;75:1165-73.
100. Marzi SJ, Leung SK, Ribarska T, et al. A histone acetylome-wide association study of Alzheimer’s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat Neurosci 2018;21:1618-27.
101. Nott A, Holtman IR, Coufal NG, et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science 2019;366:1134-9.
102. Fetahu IS, Ma D, Rabidou K, et al. Epigenetic signatures of methylated DNA cytosine in Alzheimer’s disease. Sci Adv 2019;5:eaaw2880.
103. Wood H. Alzheimer disease: AD-susceptible brain regions exhibit altered DNA methylation. Nat Rev Neurol 2014;10:548.
104. Lin HC, Hsieh HM, Chen YH, Hu ML. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Neurotoxicology 2009;30:622-7.
105. Di Francesco A, Arosio B, Falconi A, et al. Global changes in DNA methylation in Alzheimer’s disease peripheral blood mononuclear cells. Brain Behav Immun 2015;45:139-44.
106. De Jager PL, Srivastava G, Lunnon K, et al. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 2014; 17:1156-63.
107. Lunnon K, Smith R, Hannon E, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci 2014;17:1164-70.
108. Chouliaras L, Mastroeni D, Delvaux E, et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients. Neurobiol Aging 2013;34:2091-9.
109. Tong Z, Han C, Qiang M, et al. Age-related formaldehyde interferes with DNA methyltransferase function, causing memory loss in Alzheimer's disease. Neurobiol Aging 2015;36:100-10.
110. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer’s disease. PLoS One 2009;4:e6617.
111. Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M. Global changes in DNA methylation and hydroxymethylation in Alzheimer’s disease human brain. Neurobiol Aging 2014;35:1334-44.
112. Bakulski KM, Dolinoy DC, Sartor MA, et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 2012;29:571-88.
113. Nativio R, Lan Y, Donahue G, et al. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease. Nat Genet 2020;52:1024-1035.
114. Lu T, Ang CE, Zhuang X. Spatially resolved epigenomic profiling of single cells in complex tissues. Cell 2022;185:4448-4464.e17.
115. Francis YI, Fà M, Ashraf H, et al. Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J Alzheimers Dis 2009;18:131-9.
116. Ricobaraza A, Cuadrado-Tejedor M, Pérez-Mediavilla A, Frechilla D, Del Río J, García-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 2009;34:1721-32.
117. Kim C, Choi H, Jung ES, et al. HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons. PLoS One 2012;7:e42983.
118. Onishi T, Maeda R, Terada M, et al. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice. Sci Rep 2021;11:15423.
119. Gräff J, Rei D, Guan JS, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 2012;483:222-6.
120. Zhang K, Schrag M, Crofton A, Trivedi R, Vinters H, Kirsch W. Targeted proteomics for quantification of histone acetylation in Alzheimer’s disease. Proteomics 2012;12:1261-8.
121. Anderson KW, Turko IV. Histone post-translational modifications in frontal cortex from human donors with Alzheimer’s disease. Clin Proteomics 2015;12:26.
122. Lithner CU, Lacor PN, Zhao WQ, et al. Disruption of neocortical histone H3 homeostasis by soluble Aβ: implications for Alzheimer’s disease. Neurobiol Aging 2013;34:2081-90.
123. Persico G, Casciaro F, Amatori S, et al. Histone H3 lysine 4 and 27 trimethylation landscape of human Alzheimer's disease. Cells 2022;11:734.
124. Zheng Y, Liu A, Wang ZJ, et al. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease. Brain 2019;142:787-807.
125. Cao Q, Wang W, Williams JB, Yang F, Wang ZJ, Yan Z. Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer's disease. Sci Adv 2020;6:eabc8096.
127. Wang E, Lemos Duarte M, Rothman LE, Cai D, Zhang B. Non-coding RNAs in Alzheimer's disease: perspectives from omics studies. Hum Mol Genet 2022;31:R54-R61.
128. Lauretti E, Dabrowski K, Praticò D. The neurobiology of non-coding RNAs and Alzheimer's disease pathogenesis: Pathways, mechanisms and translational opportunities. Ageing Res Rev 2021;71:101425.
129. Yu CC, Jiang T, Yang AF, Du YJ, Wu M, Kong LH. Epigenetic modulation on tau phosphorylation in Alzheimer's disease. Neural Plast 2019;2019:6856327.
130. Lan Z, Chen Y, Jin J, Xu Y, Zhu X. Long non-coding RNA: insight into mechanisms of Alzheimer's disease. Front Mol Neurosci 2022;14:821002.
131. Praticò D. The functional role of microRNAs in the pathogenesis of tauopathy. Cells 2020;9:2262.
132. Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives. Mol Neurodegener 2021;16:76.
133. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007;317:1220-4.
134. Islam MR, Kaurani L, Berulava T, et al. A microRNA signature that correlates with cognition and is a target against cognitive decline. EMBO Mol Med 2021;13:e13659.
135. Manzine PR, Pelucchi S, Horst MA, et al. microRNA 221 targets ADAM10 mRNA and is downregulated in Alzheimer's disease. J Alzheimers Dis 2018;61:113-123.
136. Lau P, Bossers K, Janky R, et al. Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med 2013;5:1613-34.
137. Geekiyanage H, Jicha GA, Nelson PT, Chan C. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol 2012;235:491-6.
138. Jain G, Stuendl A, Rao P, et al. A combined miRNA-piRNA signature to detect Alzheimer's disease. Transl Psychiatry 2019;9:250.
139. Hosseinian S, Arefian E, Rakhsh-Khorshid H, et al. A meta-analysis of gene expression data highlights synaptic dysfunction in the hippocampus of brains with Alzheimer's disease. Sci Rep 2020;10:8384.
140. Dobricic V, Schilling M, Schulz J, et al. Differential microRNA expression analyses across two brain regions in Alzheimer's disease. Transl Psychiatry 2022;12:352.
141. Long JM, Maloney B, Rogers JT, Lahiri DK. Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: Implications in Alzheimer's disease. Mol Psychiatry 2019;24:345-363.
142. Kumar S, Reddy AP, Yin X, Reddy PH. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease. Biochim Biophys Acta Mol Basis D ;1865:2428-40.
143. Hu YB, Zhang YF, Ren RJ, et al. microRNA-425 loss mediates amyloid plaque microenvironment heterogeneity and promotes neurodegenerative pathologies. Aging Cell 2021;20:e13454.
144. Qiu W, Guo X, Lin X, et al. Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease. Neurobiol Aging 2017;57:170-177.
145. Balietti M, Conti F. Environmental enrichment and the aging brain: is it time for standardization? Neurosci Biobehav Rev 2022;139:104728.
146. Liew AKY, Teo CH, Soga T. The molecular effects of environmental enrichment on Alzheimer's disease. Mol Neurobiol 2022;59:7095-118.
147. Griñan-Ferré C, Pérez-Cáceres D, Gutiérrez-Zetina SM, et al. Environmental enrichment improves behavior, cognition, and brain functional markers in young senescence-accelerated prone mice (SAMP8). Mol Neurobiol 2016;53:2435-50.
148. Schmidt S, Haase M, Best L, et al. Restoring age-related cognitive decline through environmental enrichment: a transcriptomic approach. Cells 2022;11:3864.
149. Zhang ZZ, Zeng LP, Chen J, et al. Long-term environmental enrichment relieves dysfunctional cognition and synaptic protein levels induced by prenatal inflammation in older CD-1 mice. Neural Plast 2022;2022:1483101.
150. Herring A, Yasin H, Ambrée O, Sachser N, Paulus W, Keyvani K. Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice. Brain Pathol 2008;18:32-9.
151. Wei Z, Meng X, El Fatimy R, et al. Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways. Neurobiol Dis 2020;134:104617.
152. Bourdon E, Belmin J. Enriched gardens improve cognition and independence of nursing home residents with dementia: a pilot controlled trial. Alzheimers Res Ther 2021;13:116.
153. Liśkiewicz A, Przybyła M, Wojakowska A, et al. Physical activity reduces anxiety and regulates brain fatty acid synthesis. Mol Brain 2020;13:62.
154. Tai F, Wang C, Deng X, et al. Treadmill exercise ameliorates chronic REM sleep deprivation-induced anxiety-like behavior and cognitive impairment in C57BL/6J mice. Brain Res Bull 2020;164:198-207.
155. Choi SH, Bylykbashi E, Chatila ZK, et al. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model. Science 2018; 361:eaan8821.
156. Horowitz AM, Fan X, Bieri G, et al. Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain. Science 2020;369:167-173.
157. Sakhare A, Stradford J, Ravichandran R, et al. Simultaneous exercise and cognitive training in virtual reality phase 2 pilot study: impact on brain health and cognition in older adults. Brain Plast 2021;7:111-130.
158. Chin LM, Keyser RE, Dsurney J, Chan L. Improved cognitive performance following aerobic exercise training in people with traumatic brain injury. Arch Phys Med Rehabil 2015;96:754-9.
159. Lourenco MV, Frozza RL, de Freitas GB, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nat Med 2019;25:165-75.
160. Freitas GB, Lourenco MV MV, De Felice FG, et al. Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease. J Neurochem 2020;155:602-11.
161. Azimi M, Gharakhanlou R, Naghdi N, Khodadadi D, Heysieattalab S. Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway. Peptides 2018;102:78-88.
162. Islam MR, Valaris S, Young MF, et al. Exercise hormone irisin is a critical regulator of cognitive function. Nat Metab 2021;3:1058-70.
163. Pignataro P, Dicarlo M, Zerlotin R, et al. FNDC5/Irisin system in neuroinflammation and neurodegenerative diseases: update and novel perspective. Int J Mol Sci 2021;22:1605.
164. Chen K, Wang K, Wang T. Protective effect of irisin against Alzheimer's disease. Front Psychiatry 2022;13:967683.
165. Han R, Liu Z, Sun N, et al. BDNF alleviates neuroinflammation in the hippocampus of type 1 diabetic mice via blocking the aberrant HMGB1/RAGE/NF-κB pathway. Aging Dis 2019;10:611-25.
166. Gao L, Zhang Y, Sterling K, Song W. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. Transl Neurodegener 2022;11:4.
167. Nigam SM, Xu S, Kritikou JS, Marosi K, Brodin L, Mattson MP. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP. J Neurochem 2017;142:286-96.
168. Noda Y, Kuzuya A, Tanigawa K, et al. Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid beta production in Alzheimer’s disease. Mol Brain 2018;11:61.
169. Tan ZX, Dong F, Wu LY, Feng YS, Zhang F. The beneficial role of exercise on treating Alzheimer's disease by inhibiting β-amyloid peptide. Mol Neurobiol 2021;58:5890-06.
170. Brown BM, Peiffer J, Rainey-Smith SR. Exploring the relationship between physical activity, beta-amyloid and tau: a narrative review. Ageing Res Rev 2019;50:9-18.
171. De la Rosa A, Olaso-Gonzalez G, Arc-Chagnaud C, et al. Physical exercise in the prevention and treatment of Alzheimer's disease. J Sport Health Sci 2020;9:394-404.
172. Almeida EJR, Ibrahim HJ, Chitolina Schetinger MR, de Andrade CM, Cardoso AM. Modulation of inflammatory mediators and microglial activation through physical exercise in Alzheimer's and Parkinson's diseases. Neurochem Res 2022;47:3221-40.
173. Ohia-Nwoko O, Montazari S, Lau YS, Eriksen JL. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener 2014;9:54.
174. Liu HL, Zhao G, Zhang H, Shi LD. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 2013;256:261-72.
175. Kang EB, Cho JY. Effect of treadmill exercise on PI3K/AKT/mTOR, autophagy, and Tau hyperphosphorylation in the cerebral cortex of NSE/htau23 transgenic mice. J Exerc Nutr Biochem 2015;19:199-209.
176. Peng Y, Chi R, Liu G, Tian W, Zhang J, Zhang R. Aerobic exercise regulates apoptosis through the PI3K/Akt/GSK-3β signaling pathway to improve cognitive impairment in Alzheimer's disease mice. Neural Plast 2022;2022:1500710.
177. Lv J, Jiang S, Yang Z, et al. PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders. Ageing Res Rev 2018;44:8-21.
178. Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 2011;93:884S-90.
179. Wang R, Li JJ, Diao S, et al. Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons. Cell Metab 2013;17:685-94.
180. Katsouri L, Lim YM, Blondrath K, et al. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model. Proc Natl Acad Sci USA 2016;113:12292-7.
181. Shah SA, Yoon GH, Chung SS, et al. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits. Mol Psychiatry 2017;22:407-16.
182. Porquet D, Casadesús G, Bayod S, et al. Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8. Age 2013;35:1851-65.
183. Zhang Z, Shen Q, Wu X, Zhang D, Xing D. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models. Aging Cell 2020;19:e13054.
184. Revilla S, Suñol C, García-Mesa Y, Giménez-Llort L, Sanfeliu C, Cristòfol R. Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology 2014;81:55-63.
185. Koo JH, Kang EB, Oh YS, Yang DS, Cho JY. Treadmill exercise decreases amyloid-beta burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer’s disease. Exp Neurol 2017;288:142-52.
186. Gomez-Pinilla F, Zhuang Y, Feng J, Ying Z, Fan G. Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci 2011;33:383-90.
187. Intlekofer KA, Berchtold NC, Malvaez M, et al. Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism. Neuropsychopharmacology 2013;38:2027-34.
188. Sleiman SF, Henry J, Al-Haddad R, et al. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. Elife 2016;5:e15092.
189. Collins A, Hill LE, Chandramohan Y, et al. Exercise improves cognitive responses to psychological stress through enhancement of epigenetic mechanisms and gene expression in the dentate gyrus. PLoS One 2009;4:e4330.
190. Elsner VR, Lovatel GA, Bertoldi K, et al. Effect of different exercise protocols on histone acetyltransferases and histone deacetylases activities in rat hippocampus. Neuroscience 2011;192:580-7.
191. Elsner VR, Lovatel GA, Moysés F, et al. Exercise induces age-dependent changes on epigenetic parameters in rat hippocampus: a preliminary study. Exp Gerontol 2013;48:136-9.
192. Abel JL, Rissman EF. Running-induced epigenetic and gene expression changes in the adolescent brain. Int J Dev Neurosci 2013;31:382-90.
193. Lovatel GA, Elsner VR, Bertoldi K, et al. Treadmill exercise induces age-related changes in aversive memory, neuroinflammatory and epigenetic processes in the rat hippocampus. Neurobiol Learn Mem 2013;101:94-102.
194. Patki G, Solanki N, Atrooz F, et al. Novel mechanistic insights into treadmill exercise based rescue of social defeat-induced anxiety-like behavior and memory impairment in rats. Physiol Behav 2014; 130:135-44.
195. Spindler C, Cechinel LR, Basso C, et al. Treadmill exercise alters histone acetyltransferases and histone deacetylases activities in frontal cortices from wistar rats. Cell Mol Neurobiol 2014;34:1097-101.
196. Cosín-Tomás M, Alvarez-López MJ, Sanchez-Roige S, et al. Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise. Front Aging Neurosci 2014;6:51.
197. Bao TH, Miao W, Han JH, et al. Spontaneous running wheel improves cognitive functions of mouse associated with miRNA expressional alteration in hippocampus following traumatic brain injury. J Mol Neurosci 2014;54:622-9.
198. Hu T, Zhou FJ, Chang YF, et al. miR21 is Associated with the Cognitive improvement following voluntary running wheel exercise in TBI mice. J Mol Neurosci 2015;57:114-22.
199. Pan-Vazquez A, Rye N, Ameri M, et al. Impact of voluntary exercise and housing conditions on hippocampal glucocorticoid receptor, miR-124 and anxiety. Mol Brain 2015;8:40.
200. Ieraci A, Mallei A, Musazzi L, Popoli M. Physical exercise and acute restraint stress differentially modulate hippocampal brain-derived neurotrophic factor transcripts and epigenetic mechanisms in mice. Hippocampus 2015;25:1380-92.
201. Zhong T, Ren F, Huang CS, et al. Swimming exercise ameliorates neurocognitive impairment induced by neonatal exposure to isoflurane and enhances hippocampal histone acetylation in mice. Neuroscience 2016;316:378-88.
202. Kim TK, Lee JE, Kim JE, et al. G9a-Mediated regulation of OXT and AVP expression in the basolateral amygdala mediates stress-induced lasting behavioral depression and its reversal by exercise. Mol Neurobiol 2016;53:2843-56.
203. Maejima H, Kanemura N, Kokubun T, Murata K, Takayanagi K. Exercise enhances cognitive function and neurotrophin expression in the hippocampus accompanied by changes in epigenetic programming in senescence-accelerated mice. Neurosci Lett 2018;665:67-73.
204. Sølvsten CAE, de Paoli F, Christensen JH, Nielsen AL. Voluntary physical exercise induces expression and epigenetic remodeling of vegfa in the rat hippocampus. Mol Neurobiol 2018;55:567-82.
205. Li X, Inoue T, Hayashi M, Maejima H. Exercise enhances the expression of brain-derived neurotrophic factor in the hippocampus accompanied by epigenetic alterations in senescence-accelerated mice prone 8. Neurosci Lett 2019;706:176-81.
206. de Meireles LCF, Galvão F Jr, Walker DM, et al. Exercise modalities improve aversive memory and survival rate in aged rats: role of hippocampal epigenetic modifications. Mol Neurobiol 2019;56:8408-19.
207. Zhang J, Li J, Zhu Y, Miao Z, Tian Y. Forced running exercise mitigates radiation-induced cognitive deficits via regulated DNA hydroxymethylation. Epigenomics 2020;12:385-96.
208. Davaa G, Hong JY, Kim TU, Lee SJ, Kim SY, Hong K, Hyun JK. Exercise ameliorates spinal cord injury by changing DNA methylation. Cells 2021;10:143.
209. Maejima H, Kitahara M, Takamatsu Y, Mani H, Inoue T. Effects of exercise and pharmacological inhibition of histone deacetylases (HDACs) on epigenetic regulations and gene expressions crucial for neuronal plasticity in the motor cortex. Brain Res 2021;1751:147191.
210. Liu SJ, Cai TH, Fang CL, et al. Long-term exercise training down-regulates m6A RNA demethylase FTO expression in the hippocampus and hypothalamus: an effective intervention for epigenetic modification. BMC Neurosci 2022;23:54.
211. Barrès R, Yan J, Egan B, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 2012;15:405-11.
212. Bajpeyi S, Covington JD, Taylor EM, Stewart LK, Galgani JE, Henagan TM. Skeletal Muscle PGC1α -1 Nucleosome Position and -260 nt DNA Methylation Determine Exercise Response and Prevent Ectopic Lipid Accumulation in Men. Endocrinology 2017;158:2190-9.
213. Yu M, Stepto NK, Chibalin AV, et al. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol 2003;546:327-35.
214. Smith JA, Kohn TA, Chetty AK, Ojuka EO. CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene. Am J Physiol Endocrinol Metab 2008;295:E698-704.
215. Chandramohan Y, Droste SK, Arthur JS, Reul JM. The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway. Eur J Neurosci 2008;27:2701-13.
216. Gomez-Pinilla F, Zhuang Y, Feng J, Ying Z, Fan G. Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci 2011;33:383-90.
217. Mackay CP, Kuys SS, Brauer SG. The effect of aerobic exercise on brain-derived neurotrophic factor in people with neurological disorders: a systematic review and meta-analysis. Neural Plast 2017;2017:4716197.
218. Wang R, Holsinger RMD. Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia. Ageing Res Rev 2018; 48:109-121.
219. Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011;108:3017-22.
220. Maass A, Düzel S, Brigadski T, et al. Relationships of peripheral IGF-1, VEGF and BDNF levels to exercise-related changes in memory, hippocampal perfusion and volumes in older adults. Neuroimage 2016;131:142-54.
221. Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab 2013;18:649-59.
222. El Hayek L, Khalifeh M, Zibara V, et al. Lactate mediates the effects of exercise on learning and memory through sirt1-dependent activation of hippocampal brain-derived neurotrophic factor (BDNF). J Neurosci 2019;39:2369-82.
223. Fakhraei S, Reza Almasi M, Peeri M, Gharakhanlou R. The effect of 4-week rehabilitation by aerobic exercise on hippocampus BDNF and TGF-β1 gene expressions inAβ 1-42-induced rat model of Alzheimer's disease. J Clin Neurosci 2022;95:106-11.
224. Nigam SM, Xu S, Kritikou JS, Marosi K, Brodin L, Mattson MP. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP. J Neurochem 2017;142:286-96.
225. Baranowski BJ, Hayward GC, Marko DM, MacPherson REK. Examination of BDNF treatment on BACE1 activity and acute exercise on brain BDNF signaling. Front Cell Neurosci 2021;15:665867.
226. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008;455:411- 5.
227. Vaynman S, Ying Z, Gomez-Pinilla F. Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience 2003;122:647-57.
228. Vaynman S, Ying Z, Gomez-Pinilla F. The select action of hippocampal calcium calmodulin protein kinase II in mediating exercise-enhanced cognitive function. Neuroscience 2007;144:825-33.
229. Zocchi L, Sassone-Corsi P. SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 2012;7:695-700.
230. Marton O, Koltai E, Takeda M, et al. The rate of training response to aerobic exercise affects brain function of rats. Neurochem Int 2016;99:16-23.
231. Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol 2011;111:1066-71.
232. Lee HR, Shin HK, Park SY, et al. Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β. J Neurosci Res 2014;92:1581-90.
233. Min SW, Sohn PD, Li Y, et al. SIRT1 deacetylates Tau and reduces pathogenic Tau spread in a mouse model of tauopathy. J Neurosci 2018;38:3680-8.
234. Dungan CM, Valentino T, Vechetti IJ Jr, et al. Exercise-mediated alteration of hippocampal Dicer mRNA and miRNAs is associated with lower BACE1 gene expression and Aβ(1-42) in female 3xTg-AD mice. J Neurophysiol 2020;124:1571-7.
235. Wang X, Liu P, Zhu H, et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 2009;80:268-73.
236. Jian C, Lu M, Zhang Z, et al. miR-34a knockout attenuates cognitive deficits in APP/PS1 mice through inhibition of the amyloidogenic processing of APP. Life Sci 2017;182:104-11.
237. Sarkar S, Engler-Chiurazzi EB, Cavendish JZ, et al. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology. Brain Res 2019;1721:146327.
238. Xu L, Zheng YL, Yin X, et al. Excessive treadmill training enhances brain-specific microrna-34a in the mouse hippocampus. Front Mol Neurosci 2020;13:7.
239. Kou X, Li J, Liu X, et al. Swimming attenuates d-galactose-induced brain aging via suppressing miR-34a-mediated autophagy impairment and abnormal mitochondrial dynamics. J Appl Physiol 2017;122:1462-9.
240. Lin Y, Shen J, Li D, et al. MiR-34a contributes to diabetes-related cochlear hair cell apoptosis via SIRT1/HIF-1α signaling. Gen Comp Endocrinol 2017;246:63-70.
241. Zhang H, Zhang XM, Zong DD, et al. miR-34a-5p up-regulates the IL-1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons. FEBS Open Bio 2021;11:300-11.
242. Wang RY, Phang RZ, Hsu PH, Wang WH, Huang HT, Liu IY. In vivo knockdown of hippocampal miR-132 expression impairs memory acquisition of trace fear conditioning. Hippocampus 2013;23:625-33.
243. Scott HL, Tamagnini F, Narduzzo KE, et al. MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci 2012;36:2941-8.
244. Hansen KF, Karelina K, Sakamoto K, Wayman GA, Impey S, Obrietan K. miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct 2013;218:817-31.
245. Radom-Aizik S, Zaldivar F, Leu SY, Adams GR, Oliver S, Cooper DM. Effects of exercise on microRNA expression in young males peripheral blood mononuclear cells. Clin Transl Sci 2012;5:32-8.
246. Dong J, Liu Y, Zhan Z, Wang X. MicroRNA-132 is associated with the cognition improvement following voluntary exercise in SAMP8 mice. Brain Res Bull 2018;140:80-7.
247. Sadeghian R, Shahidi S, Komaki A, et al. Synergism effect of swimming exercise and genistein on the inflammation, oxidative stress, and VEGF expression in the retina of diabetic-ovariectomized rats. Life Sci 2021;284:119931.
248. Shi L, Zhang R, Li T, et al. Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway. Aging 2020;13:4590-604.
249. Tan Z, Chen Y, Xie W, Liu X, Zhu Y, Zhu Y. Nimodipine attenuates tau phosphorylation at Ser396 via miR-132/GSK-3β pathway in chronic cerebral hypoperfusion rats. Eur J Pharmacol 2018;819:1-8.
250. Qu J, Xiong X, Hujie G, Ren J, Yan L, Ma L. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1. Cell Cycle 2021;20:2309-2320.
251. Smith PY, Hernandez-Rapp J, Jolivette F, et al. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 2015;24:6721-35.
252. Hernandez-Rapp J, Rainone S, Goupil C, et al. microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice. Sci Rep 2016;6:30953.
253. Nielsen S, Åkerström T, Rinnov A, et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS One 2014;9:e87308.
254. Sierksma A, Lu A, Salta E, et al. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Mol Neurodegener 2018;13:54.
255. Su W, Aloi MS, Garden GA. MicroRNAs mediating CNS inflammation:small regulators with powerful potential. Brain Behav Immun 2016;52:1-8.
256. Liang C, Zou T, Zhang M, et al. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease. Theranostics 2021;11:4103-21.
257. Maffioletti E, Milanesi E, Ansari A, et al. miR-146a plasma levels are not altered in Alzheimer's disease but correlate with age and illness severity. Front Aging Neurosci 2020;11:366.
258. Ansari A, Maffioletti E, Milanesi E, et al. miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 2019;82:102-9.
259. Olcum M, Tufekci KU, Durur DY, et al. Ethyl pyruvate attenuates microglial NLRP3 inflammasome activation via inhibition of HMGB1/NF-κB/miR-223 signaling. Antioxidants 2021;10:745.
260. La Rosa F, Mancuso R, Agostini S, et al. Pharmacological and epigenetic regulators of NLRP3 inflammasome activation in Alzheimer's disease. Pharmaceuticals 2021;14:1187.
261. Jia LH, Liu YN. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease. Cell Biochem Funct 2016;34:233-7.
262. Wei H, Xu Y, Chen Q, Chen H, Zhu X, Li Y. Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis 2020;11:290.
263. Harraz MM, Eacker SM, Wang X, Dawson TM, Dawson VL. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci USA 2012; 109:18962-7.
